Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)

J. A. Kulas; W. F. Franklin; N. A. Smith; G. D. Manocha; K. L. Puig; K. Nagamoto-Combs; R. D. Hendrix; G. Taglialatela; S. W. Barger; C. K. Combs

doi:10.1152/ajpendo.zh1-8043-corr.2019

Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)

J. A. Kulas, W. F. Franklin, N. A. Smith, G. D. Manocha, K. L. Puig, K. Nagamoto-Combs, R. D. Hendrix, G. Taglialatela, S. W. Barger, C. K. Combs

Neurology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In DISCLOSURES, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”

Original language	English (US)
Pages (from-to)	E345
Journal	American Journal of Physiology - Endocrinology and Metabolism
Volume	316
Issue number	2
DOIs	https://doi.org/10.1152/ajpendo.zh1-8043-corr.2019
State	Published - Feb 1 2019

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Physiology
Physiology (medical)

Access to Document

10.1152/ajpendo.zh1-8043-corr.2019

Fingerprint

Dive into the research topics of 'Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)'. Together they form a unique fingerprint.

Cite this

Kulas, J. A., Franklin, W. F., Smith, N. A., Manocha, G. D., Puig, K. L., Nagamoto-Combs, K., Hendrix, R. D., Taglialatela, G., Barger, S. W., & Combs, C. K. (2019). Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018). American Journal of Physiology - Endocrinology and Metabolism, 316(2), E345. https://doi.org/10.1152/ajpendo.zh1-8043-corr.2019

Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018). / Kulas, J. A.; Franklin, W. F.; Smith, N. A. et al.
In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 316, No. 2, 01.02.2019, p. E345.

Research output: Contribution to journal › Comment/debate › peer-review

Kulas, JA, Franklin, WF, Smith, NA, Manocha, GD, Puig, KL, Nagamoto-Combs, K, Hendrix, RD, Taglialatela, G, Barger, SW & Combs, CK 2019, 'Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)', American Journal of Physiology - Endocrinology and Metabolism, vol. 316, no. 2, pp. E345. https://doi.org/10.1152/ajpendo.zh1-8043-corr.2019

Kulas JA, Franklin WF, Smith NA, Manocha GD, Puig KL, Nagamoto-Combs K et al. Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018). American Journal of Physiology - Endocrinology and Metabolism. 2019 Feb 1;316(2):E345. doi: 10.1152/ajpendo.zh1-8043-corr.2019

Kulas, J. A. ; Franklin, W. F. ; Smith, N. A. et al. / Corrigendum : Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018). In: American Journal of Physiology - Endocrinology and Metabolism. 2019 ; Vol. 316, No. 2. pp. E345.

@article{4d8ab7f4c1ec44239b98da414e47dfd5,

title = "Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)",

abstract = "Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In DISCLOSURES, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”",

author = "Kulas, \{J. A.\} and Franklin, \{W. F.\} and Smith, \{N. A.\} and Manocha, \{G. D.\} and Puig, \{K. L.\} and K. Nagamoto-Combs and Hendrix, \{R. D.\} and G. Taglialatela and Barger, \{S. W.\} and Combs, \{C. K.\}",

note = "Publisher Copyright: {\textcopyright} 2019 the American Physiological Society.",

year = "2019",

month = feb,

day = "1",

doi = "10.1152/ajpendo.zh1-8043-corr.2019",

language = "English (US)",

volume = "316",

pages = "E345",

journal = "American Journal of Physiology - Endocrinology and Metabolism",

issn = "0193-1849",

publisher = "American Physiological Society",

number = "2",

}

TY - JOUR

T1 - Corrigendum

T2 - Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)

AU - Kulas, J. A.

AU - Franklin, W. F.

AU - Smith, N. A.

AU - Manocha, G. D.

AU - Puig, K. L.

AU - Nagamoto-Combs, K.

AU - Hendrix, R. D.

AU - Taglialatela, G.

AU - Barger, S. W.

AU - Combs, C. K.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In DISCLOSURES, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”

AB - Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues. Am J Physiol Endocrinol Metab 316: E106–E120, 2019. First published November 13, 2018; doi:10.1152/ajpendo.00279.2018.—In DISCLOSURES, the following statement was omitted in error: “S. W. Barger receives royalties from Merck/Sigma-Aldrich for the sales of secreted amyloid precursor protein.”

UR - https://www.scopus.com/pages/publications/85061150736

UR - https://www.scopus.com/inward/citedby.url?scp=85061150736&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.zh1-8043-corr.2019

DO - 10.1152/ajpendo.zh1-8043-corr.2019

M3 - Comment/debate

C2 - 30721099

AN - SCOPUS:85061150736

SN - 0193-1849

VL - 316

SP - E345

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

IS - 2

ER -

Corrigendum: Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (Am J Physiol Endocrinol Metab, (2019) 316, (E106-E120), 10.1152/ajpendo.00279.2018)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this